Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amikacin PK in Neonates with Perinatal Asphyxia
NCT04867993Unknown
- Sponsor
- University of Sarajevo
- Start
- Aug 2018
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of amikacin in bacterial infection (2 arms), sponsored by University of Sarajevo. Primary endpoints: Maximum Plasma Concentration at 5 years, Minimum Plasma Concentration at 5 years and 5 more. Status: unknown.
02
Drugs
amikacin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT04867993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04867993.